GLENMARK PHARMACEUTICALS LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of GLENMARK for the last quarter is 25.07 B INR, and it's 21.85% lower compared to the previous quarter. The net income of Q3 23 is -3.51 B INR.